GENOSS
South Korean medical device company developing orthopedic, cardiovascular, aesthetic, and dental products, including 3D-printed titanium spinal cages using SLS/PBF technology.
- CEO / Founder
- Sung-Min Chung (정성민)
- Team Size
- 201-500
- Stage
- Active
- Latest Round
- Bootstrapped
Technology & Products
Key Products
GENOSS 3d Cage (Cervical & Lumbar titanium spinal cages, 3D-printed via SLS); MONALISA Filler (hyaluronic acid dermal fillers); OSTEON bone graft substitutes; Cardiovascular stents (DES, DCB); PICC catheters; Dental biomaterials (zirconia blocks, cements, impression materials); Bright cosmetic line; iCT injection device; WBCT 3D Viewer software.
Technological Advantage
Proprietary SLS 3D printing process for titanium spinal implants with controlled porosity (~88%) and diamond pore architecture; ability to produce patient-specific implants; broad regulatory approvals across FDA, CE, KFDA, NMPA (China), and 60+ countries; vertically integrated R&D and manufacturing.
Differentiation
Value Proposition
Comprehensive medical device manufacturer leveraging 3D printing (SLS/PBF) for titanium spinal cages with ~88% porosity, combined with a broad portfolio spanning cardiovascular stents, dermal fillers, dental biomaterials, and cosmetic products.
How They Differentiate
Differentiates through in-house 3D printing (SLS/PBF) for orthopedic implants with porous structure mimicking bone, combined with a uniquely broad medical device portfolio (cardiovascular, aesthetic, dental, ENT) under one company. Invests ~30% of annual revenue in R&D.
Market & Competition
Target Customers
Hospitals, spine surgeons, interventional cardiologists, dermatologists, dentists, and medical device distributors globally.
Industry Verticals
Orthopedic Surgery; Cardiovascular Intervention; Aesthetic Medicine; Dentistry; ENT
Competitors
K2M (Stryker) with 3D-printed spinal cages; Medtronic with titanium/PEEK spinal implants; L&K Biomed (Korean competitor in spinal implants); Osstem Implant (dental); Mantiz (Korean spinal implant company).
Growth & Milestones
Major Milestones
2004: Company founded; 2021: Established GENOSS Shanghai subsidiary; 2023: Relocated HQ to Gwanggyo Dentium Knowledge Industry Center; 2023: 3D Cervical Cage Wing Type approved in South Korea; 2024: MDSAP Certification achieved; 2025: OSTEON Xeno approved in China; 2025: CGMP Certification achieved.
Notable Customers
Distributes to 60+ countries including USA, China, Japan, Russia, Brazil, UAE, and across Europe and Southeast Asia.